General description
INN
Blinatumomab
ATC codes
Medicine type
Biological agent
EML status history
First added in 2025
(TRS
1064)
for
B lymphoblastic leukaemia or lymphoma, not elsewhere classified
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
- Parenteral > General injections > IV: 35 µg in vial; 38.5 µg in vial